Your browser doesn't support javascript.
loading
Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering Efficacy.
Rhee, Moo-Yong; Kim, Kyung-Jin; Kim, Sang-Hyun; Yoon, Young Won; Rha, Seung-Woon; Hong, Soon Jun; Kwak, Choong-Hwan; Kim, Weon; Nam, Chang-Wook; Park, Tae-Ho; Hong, Taek-Jong; Park, Sungha; Ahn, Youngkeun; Lee, Namho; Jeon, Hui-Kyung; Jeon, Dong Woon; Han, Kyoo-Rok; Moon, Keon-Woong; Chae, In-Ho; Kim, Hae-Young; Kim, Hyo-Soo.
Afiliación
  • Rhee MY; Cardiovascular Center, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.
  • Kim KJ; Division of Cardiology, Department of Internal Medicine, Ewha Womans University Medical Center, Ewha Womans University School of Medicine, Seoul, Republic of Korea.
  • Kim SH; Division of Cardiology, Department of Internal Medicine, Boramae Medical Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yoon YW; Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Rha SW; Department of Internal Medicine, Medical College, Korea University, Seoul, Republic of Korea.
  • Hong SJ; Division of Cardiology, Department of Cardiovascular Center, Korea University Anam Hospital, Seoul, Republic of Korea.
  • Kwak CH; Division of Cardiology, Department of Cardiovascular Center, Gyeongsang National University Hospital, Jinju, Republic of Korea.
  • Kim W; Cardiovascular Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.
  • Nam CW; Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University, Daegu, Republic of Korea.
  • Park TH; Department of Internal Medicine, Cardiology Division, Dong-A University Hospital, Busan, Republic of Korea.
  • Hong TJ; Pusan National University Hospital, Busan, Republic of Korea.
  • Park S; Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Ahn Y; Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.
  • Lee N; Division of Cardiology, Department of Internal Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
  • Jeon HK; Department of Cardiovascular, Uijeongbu, Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Jeon DW; Division of Cardiology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
  • Han KR; Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Republic of Korea.
  • Moon KW; Cardiology Division, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Republic of Korea.
  • Chae IH; Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim HY; Department of Health Policy and Management, College of Health Science & Department of Public Health Science, Graduate School, Korea University, Seoul, Republic of Korea.
  • Kim HS; Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea. Electronic address: hyosoo@snu.ac.kr.
Clin Ther ; 41(12): 2571-2592, 2019 12.
Article en En | MEDLINE | ID: mdl-31727361
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Rosuvastatina Cálcica / Ezetimiba / Hipercolesterolemia / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Ther Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Rosuvastatina Cálcica / Ezetimiba / Hipercolesterolemia / Anticolesterolemiantes Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Clin Ther Año: 2019 Tipo del documento: Article